Novozymes revenue and financials
In the fiscal year ended December 2025, Novozymes reported revenue of €4.16B (+8.45% year over year). Net income was €583.6M, a net margin of 14.0%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +8.45%
- 2025 vs 2024
- Net income growth
- +90.84%
- 2025 vs 2024
- Net margin
- 14.0%
- 2024: 8.0%
How Novozymes is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 17.2% a year on average over the last 5 years
Compound annual growth rate: from €1.88B in 2020 to €4.16B in 2025.
Revenue has grown for 5 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin fell from 25.5% to 23.1%
Operating income over revenue, 2022 → 2025: 2.4 percentage points.
Profits turn into cash: free cash flow equal to 139% of net income
Totals for fiscal years 2023–2025: free cash flow €1.8B, net income €1.3B.
Shares outstanding up 65.5% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4,158 | 3,834 | 2,402 | 2,360 | 2,010 | 1,883 | 1,925 | 1,927 | 1,952 | 1,904 |
| Cost of revenue | 1,852 | 1,840 | 1,097 | 1,071 | 849 | 828 | 855 | 815 | 820 | 804 |
| Gross profit | 2,305 | 1,993 | 1,305 | 1,289 | 1,161 | 1,055 | 1,069 | 1,111 | 1,132 | 1,099 |
| Selling, general and administrative | 912 | 766 | 446 | 430 | 380 | 309 | 329 | 313 | 332 | 325 |
| Research and development | 449 | 413 | 271 | 267 | 266 | 256 | 263 | 248 | 255 | 251 |
| Operating income | 962 | 843 | 611 | 602 | 523 | 492 | 480 | 557 | 553 | 539 |
| EBIT | 962 | 843 | 611 | 602 | 523 | 492 | 480 | 557 | 553 | 539 |
| EBITDA | 1,537 | 1,387 | 797 | 769 | 680 | 632 | 614 | 683 | 683 | 663 |
| Interest expense | 68.3 | 76.4 | 6.5 | 13.7 | 13.7 | 8.5 | 11.5 | 1.7 | 3.6 | 4.2 |
| Pre-tax income | 743 | 417 | 525 | 613 | 527 | 473 | 509 | 527 | 521 | 522 |
| Income tax | 160 | 111 | 117 | 117 | 105 | 93.4 | 86.2 | 94.9 | 102 | 112 |
| Net income | 584 | 306 | 406 | 494 | 423 | 380 | 422 | 432 | 419 | 411 |
| Net income to common shareholders | 584 | 306 | 406 | 494 | 423 | 380 | 422 | 432 | 419 | 411 |
| Basic EPS | 1.25 | 1.10 | 1.47 | 1.79 | 1.52 | 1.35 | 1.48 | 1.49 | 1.42 | 1.37 |
| Diluted EPS | 1.25 | 0.67 | 1.46 | 1.77 | 1.51 | 1.35 | 1.47 | 1.48 | 1.41 | 1.35 |
| Average shares (basic) | 467 | 278 | 276 | 277 | 278 | 280 | 285 | 290 | 295 | 300 |
| Average shares (diluted) | 467 | 278 | 278 | 279 | 280 | 282 | 287 | 292 | 297 | 303 |
| Dividend per share | 0.87 | 0.83 | — | 0.81 | 0.74 | 0.71 | 0.70 | 0.67 | 0.60 | 0.54 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,140 | 1,116 | 1,119 | 997 | 1,065 | 1,019 | 1,078 | 981 | 1,020 | 978 | 854 | 618 |
| Cost of revenue | 493 | 495 | 485 | 438 | 521 | 474 | 483 | 303 | 473 | 577 | 405 | 284 |
| Gross profit | 647 | 622 | 635 | 559 | 544 | 545 | 594 | 679 | 548 | 401 | 448 | 333 |
| Selling, general and administrative | 248 | 245 | 245 | 250 | 230 | 220 | 212 | 210 | 196 | 192 | 168 | 113 |
| Research and development | 121 | 120 | 121 | 113 | 119 | 110 | 107 | 111 | 108 | 103 | 91.6 | 70.3 |
| Operating income | 284 | 262 | 273 | 203 | 199 | 220 | 276 | 373 | 246 | 109 | 197 | 143 |
| EBIT | 284 | 262 | 273 | 203 | 199 | 220 | 276 | 373 | 246 | 109 | 197 | 143 |
| EBITDA | 441 | 419 | 423 | 358 | 346 | 356 | 413 | 539 | 382 | 245 | 313 | 163 |
| Interest expense | 32.9 | 29.9 | 8.6 | 18.3 | 15.0 | 15.7 | 19.3 | 14.1 | 18.9 | 24.5 | 18.9 | 16.1 |
| Pre-tax income | 242 | 222 | 257 | 153 | 172 | 175 | 245 | 108 | 219 | 43.0 | 47.0 | 124 |
| Income tax | 54.3 | 49.9 | 57.8 | 29.9 | 33.5 | 37.7 | 58.7 | 21.6 | 63.6 | 12.4 | 13.7 | 30.6 |
| Net income | 188 | 172 | 199 | 123 | 138 | 137 | 186 | 86.2 | 156 | 30.6 | 33.3 | 93.6 |
| Net income to common shareholders | 188 | 172 | 199 | 123 | 138 | 137 | 186 | 86.2 | 156 | 30.6 | 33.3 | 93.6 |
| Basic EPS | 0.40 | 0.37 | 0.43 | 0.26 | 0.30 | 0.29 | 0.40 | 0.31 | 0.33 | 0.06 | 0.08 | 0.34 |
| Diluted EPS | 0.40 | 0.37 | 0.43 | 0.26 | 0.30 | 0.29 | 0.40 | 0.31 | 0.33 | 0.06 | 0.08 | 0.34 |
| Average shares (basic) | 470 | 467 | 463 | 466 | 467 | 468 | 465 | 278 | 468 | 510 | 416 | 277 |
| Average shares (diluted) | 470 | 467 | 467 | 466 | 467 | 468 | 468 | 278 | 468 | 510 | 435 | 278 |
| Dividend per share | — | 0.31 | — | 0.57 | 0.00 | 0.30 | — | 0.83 | — | 0.27 | — | 0.27 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 16,349 | 15,196 | 3,809 | 3,762 | 3,329 | 2,756 | 2,737 | 2,637 | 2,468 | 2,512 |
| Current assets | 1,983 | 1,879 | 1,270 | 1,242 | 1,052 | 929 | 944 | 915 | 824 | 861 |
| Cash and equivalents | 275 | 280 | 150 | 140 | 129 | 159 | 95.2 | 96.8 | 84.9 | 109 |
| Short-term investments | 20.3 | 4.0 | 5.4 | 10.7 | — | — | — | — | — | — |
| Receivables | 915 | 863 | 583 | 557 | 510 | 434 | 489 | 439 | 390 | 416 |
| Inventory | 772 | 721 | 487 | 511 | 402 | 317 | 350 | 378 | 347 | 335 |
| Net property, plant and equipment | 2,998 | 2,968 | 1,654 | 1,623 | 1,369 | 1,292 | 1,367 | 1,298 | 1,199 | 1,163 |
| Goodwill | 6,193 | 5,605 | 265 | 270 | 272 | 148 | 129 | 145 | 149 | 156 |
| Other intangible assets | 4,896 | 4,419 | 343 | 362 | 404 | 196 | 129 | 140 | 178 | 212 |
| Long-term investments | 17.5 | 24.0 | 27.5 | 30.0 | 3.9 | 4.4 | 7.9 | 8.3 | 11.8 | 30.2 |
| Current liabilities | 2,741 | 1,088 | 973 | 936 | 763 | 559 | 634 | 740 | 615 | 479 |
| Accounts payable | 421 | 423 | 217 | 251 | 200 | 148 | 150 | 190 | 180 | 161 |
| Long-term debt | 1,145 | 1,366 | 612 | 487 | 495 | 436 | 362 | 197 | 175 | 231 |
| Total debt | 3,005 | 1,797 | 1,044 | 934 | 847 | 655 | 630 | 436 | 305 | 243 |
| Total liabilities | 5,494 | 4,020 | 1,884 | 1,849 | 1,689 | 1,245 | 1,199 | 1,106 | 955 | 931 |
| Total equity (incl. minority) | 10,855 | 11,176 | 1,926 | 1,913 | 1,641 | 1,511 | 1,537 | 1,531 | 1,513 | 1,581 |
| Retained earnings | 11,159 | 11,032 | 1,846 | 1,756 | 1,519 | 1,514 | 1,447 | 1,465 | 1,459 | 1,411 |
| Minority interest | 0.0 | 0.0 | 50.0 | 52.6 | 50.9 | 1.5 | 1.6 | 1.7 | 1.7 | 1.7 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 16,826 | 16,633 | 16,523 | 16,349 | 16,303 | 16,401 | 15,057 | 15,196 | — | 15,252 | — | 3,809 |
| Current assets | 2,275 | 2,081 | 2,046 | 1,983 | 1,956 | 2,052 | 1,946 | 1,879 | — | 1,808 | — | 1,269 |
| Cash and equivalents | 455 | 309 | 327 | 275 | 281 | 328 | 250 | 280 | — | 261 | — | 150 |
| Short-term investments | — | 4.9 | 2.2 | 20.3 | — | 37.2 | 7.0 | — | — | — | — | — |
| Receivables | 965 | 931 | 924 | 915 | 905 | 887 | 959 | 863 | — | 827 | — | 583 |
| Inventory | 845 | 836 | 793 | 772 | 742 | 800 | 730 | 721 | — | 687 | — | 487 |
| Net property, plant and equipment | 3,217 | 3,149 | 3,055 | 2,998 | 2,869 | 2,834 | 2,915 | 2,968 | — | 2,866 | — | 1,654 |
| Goodwill | 6,319 | 6,310 | 6,274 | 6,193 | 6,201 | 6,154 | 5,534 | 5,605 | — | 5,571 | — | 265 |
| Other intangible assets | 4,730 | 4,810 | 4,865 | 4,896 | 4,972 | 5,053 | 4,343 | 4,419 | — | 4,692 | — | 343 |
| Long-term investments | 15.2 | 14.9 | 16.2 | 17.5 | 20.6 | 20.2 | 22.7 | 24.0 | — | 25.7 | — | 27.5 |
| Current liabilities | 1,490 | 1,197 | 1,222 | 2,741 | 1,212 | 1,171 | 1,170 | 1,088 | — | 1,631 | — | 974 |
| Accounts payable | 371 | 366 | 364 | 421 | 298 | 302 | 318 | 423 | — | 346 | — | 217 |
| Long-term debt | 2,690 | 2,639 | 2,729 | 1,145 | 2,805 | 2,975 | 1,269 | 1,366 | — | 1,073 | — | 581 |
| Total debt | — | 3,068 | 3,212 | 3,005 | 3,108 | 3,322 | 1,699 | 1,797 | — | 1,989 | — | — |
| Total liabilities | 5,611 | 5,478 | 5,604 | 5,494 | 5,559 | 5,658 | 3,827 | 4,020 | — | 4,247 | — | 1,884 |
| Total equity (incl. minority) | 11,216 | 11,155 | 10,920 | 10,855 | 10,744 | 10,743 | 11,231 | 11,176 | — | 11,005 | 1,926 | 1,925 |
| Retained earnings | — | 11,273 | 11,091 | 11,159 | 11,039 | 11,037 | 11,204 | 11,032 | — | 10,900 | — | 1,845 |
| Minority interest | — | — | — | 0.0 | — | 0.0 | 0.0 | — | — | 1.5 | — | 50.0 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,222 | 1,020 | 557 | 539 | 546 | 585 | 428 | 493 | 546 | 517 |
| Depreciation and amortization | 575 | 544 | 186 | 183 | 172 | 156 | 150 | 126 | 130 | 124 |
| Capital expenditure | -410 | -338 | -249 | -371 | -144 | -107 | -115 | -178 | -214 | -145 |
| Investing cash flow | -1,971 | -200 | -286 | -359 | -369 | -205 | -75.1 | -186 | -224 | -182 |
| Financing cash flow | 753 | -703 | -254 | -168 | -213 | -311 | -354 | -290 | -343 | -334 |
| Dividends paid | -403 | -250 | -379 | -205 | -197 | -199 | -193 | -176 | -160 | -143 |
| Share repurchases | -99.9 | 0.0 | 0.0 | -67.2 | -202 | -202 | -268 | -268 | -269 | -269 |
| Debt issued | 1,717 | 135 | 442 | 314 | 330 | 134 | 256 | 280 | 130 | 172 |
| Debt repaid | -505 | -540 | -335 | -232 | -186 | -113 | -160 | -149 | -67.8 | -104 |
| Effect of exchange rates | -8.6 | 13.3 | -7.4 | -0.8 | 7.1 | -6.3 | -0.4 | -3.9 | -3.0 | 0.3 |
| Net change in cash | -4.7 | 130 | 10.0 | 10.5 | -29.3 | 63.2 | -1.6 | 12.2 | -24.2 | 1.2 |
| Free cash flow | 812 | 682 | 308 | 168 | 402 | — | — | — | — | — |
| Levered free cash flow | 772 | 465 | 283 | 77.3 | 266 | 395 | 277 | 244 | 301 | 315 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 375 | 356 | 167 | 328 | 467 | 320 | 106 | 229 | 263 | 352 | 177 | 151 |
| Depreciation and amortization | — | 158 | 150 | 155 | 147 | 137 | 137 | 166 | 136 | 136 | 116 | 35.3 |
| Capital expenditure | -116 | -98.5 | -79.1 | -197 | -95.3 | -72.6 | -45.4 | -127 | -76.3 | -89.7 | -45.5 | -65.5 |
| Investing cash flow | -125 | -174 | -93.1 | -226 | -165 | -1,541 | -38.3 | -98.2 | -46.6 | -24.4 | -30.5 | -80.9 |
| Financing cash flow | -103 | -206 | -25.9 | -102 | -352 | 1,309 | -102 | -121 | -209 | -284 | -89.9 | -74.5 |
| Dividends paid | -147 | 0.0 | -265 | 0.0 | -140 | -262 | 0.0 | 0.0 | -125 | -125 | — | -156 |
| Share repurchases | -14.8 | 0.0 | 0.0 | 0.0 | — | -69.1 | -30.8 | — | — | — | — | — |
| Debt issued | 88.7 | 0.0 | 1,728 | 19.8 | — | 1,670 | 26.6 | 56.1 | — | 28.1 | 50.3 | 114 |
| Debt repaid | -48.7 | -158 | -1,542 | -125 | -215 | -51.7 | -113 | -182 | -92.7 | -109 | -157 | -39.2 |
| Effect of exchange rates | 0.1 | 5.6 | 3.8 | -5.9 | 3.2 | -9.4 | 3.5 | -3.3 | 5.3 | 4.3 | 7.0 | -3.1 |
| Net change in cash | 147 | -18.5 | 51.9 | -6.0 | -46.9 | 78.7 | -30.5 | 6.9 | 12.3 | 48.0 | 63.1 | -7.9 |
| Free cash flow | 259 | 258 | 88.0 | 132 | 372 | 248 | 61.0 | 102 | 186 | 262 | 131 | 85.1 |
| Levered free cash flow | 68.6 | 152 | 105 | 141 | 289 | 238 | 63.6 | — | — | — | — | 96.4 |
Financial statements of similar companies
Companies in the group: same industry, similar size
